Michael Sakalian

1.7k total citations
32 papers, 1.4k citations indexed

About

Michael Sakalian is a scholar working on Virology, Infectious Diseases and Epidemiology. According to data from OpenAlex, Michael Sakalian has authored 32 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Virology, 11 papers in Infectious Diseases and 9 papers in Epidemiology. Recurrent topics in Michael Sakalian's work include HIV Research and Treatment (20 papers), HIV/AIDS drug development and treatment (9 papers) and Bacteriophages and microbial interactions (7 papers). Michael Sakalian is often cited by papers focused on HIV Research and Treatment (20 papers), HIV/AIDS drug development and treatment (9 papers) and Bacteriophages and microbial interactions (7 papers). Michael Sakalian collaborates with scholars based in United States, Czechia and United Kingdom. Michael Sakalian's co-authors include Jason Lanman, Peter E. Prevelige, Eric Hunter, Karl Salzwedel, Mark R. Emmett, Alan G. Marshall, TuKiet T. Lam, Stephen Barnes, Jennifer Sexton and Catherine S. Adamson and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Molecular Biology and Hepatology.

In The Last Decade

Michael Sakalian

32 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael Sakalian United States 19 754 606 441 327 279 32 1.4k
Lorna S. Ehrlich United States 19 941 1.2× 536 0.9× 602 1.4× 208 0.6× 261 0.9× 27 1.4k
Jianbo Chen United States 24 951 1.3× 640 1.1× 807 1.8× 324 1.0× 150 0.5× 41 2.0k
Ruben M. Markosyan United States 19 797 1.1× 624 1.0× 585 1.3× 549 1.7× 133 0.5× 24 1.7k
Stephen W. Mason Canada 21 470 0.6× 494 0.8× 921 2.1× 309 0.9× 294 1.1× 31 1.7k
Steve C. Pettit United States 18 962 1.3× 830 1.4× 447 1.0× 186 0.6× 121 0.4× 24 1.3k
Matteo Negroni France 24 707 0.9× 529 0.9× 637 1.4× 232 0.7× 83 0.3× 37 1.2k
Thomas Fricke United States 14 1.0k 1.4× 663 1.1× 627 1.4× 255 0.8× 119 0.4× 23 1.3k
Olga A. Nikolaitchik United States 22 865 1.1× 422 0.7× 807 1.8× 210 0.6× 95 0.3× 41 1.3k
Gabriella Rozera Italy 16 315 0.4× 342 0.6× 249 0.6× 228 0.7× 121 0.4× 55 786
Jason W. Rausch United States 28 940 1.2× 848 1.4× 1.0k 2.4× 302 0.9× 67 0.2× 55 1.8k

Countries citing papers authored by Michael Sakalian

Since Specialization
Citations

This map shows the geographic impact of Michael Sakalian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Sakalian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Sakalian more than expected).

Fields of papers citing papers by Michael Sakalian

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Sakalian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Sakalian. The network helps show where Michael Sakalian may publish in the future.

Co-authorship network of co-authors of Michael Sakalian

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Sakalian. A scholar is included among the top collaborators of Michael Sakalian based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Sakalian. Michael Sakalian is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nguyen, Albert T., Christa L. Feasley, Theodore J. Nitz, et al.. (2011). The prototype HIV-1 maturation inhibitor, bevirimat, binds to the CA-SP1 cleavage site in immature Gag particles. Retrovirology. 8(1). 101–101. 56 indexed citations
2.
Wang, Danher, Andreas Suhrbier, Adam Penn‐Nicholson, et al.. (2011). A complex adenovirus vaccine against chikungunya virus provides complete protection against viraemia and arthritis. Vaccine. 29(15). 2803–2809. 98 indexed citations
3.
Adamson, Catherine S., Michael Sakalian, Karl Salzwedel, & Eric O. Freed. (2010). Polymorphisms in Gag spacer peptide 1 confer varying levels of resistance to the HIV- 1maturation inhibitor bevirimat. Retrovirology. 7(1). 36–36. 67 indexed citations
4.
Knejzlı́k, Zdeněk, Pavel Ulbrich, Martin Strohalm, et al.. (2009). Conformational changes of the N-terminal part of Mason-Pfizer monkey virus p12 protein during multimerization. Virology. 393(1). 168–176. 4 indexed citations
5.
Hadravová, Romana, et al.. (2008). Premature processing of mouse mammary tumor virus Gag polyprotein impairs intracellular capsid assembly. Virology. 384(1). 33–37. 13 indexed citations
6.
Rumlová, Michaela, Martin Andreánsky, Michael Sakalian, et al.. (2008). The impact of altered polyprotein ratios on the assembly and infectivity of Mason-Pfizer monkey virus. Virology. 384(1). 59–68. 5 indexed citations
7.
Melana, Stella M., et al.. (2007). Characterization of Viral Particles Isolated from Primary Cultures of Human Breast Cancer Cells. Cancer Research. 67(18). 8960–8965. 56 indexed citations
8.
Salzwedel, Karl, David E. Martin, & Michael Sakalian. (2007). Maturation inhibitors: a new therapeutic class targets the virus structure.. PubMed. 9(3). 162–72. 52 indexed citations
9.
Knejzlı́k, Zdeněk, et al.. (2007). Multimerization of the p12 domain is necessary for Mason–Pfizer monkey virus Gag assembly in vitro. Virology. 365(2). 260–270. 7 indexed citations
10.
Adamson, Catherine S., Sherimay D. Ablan, Ritu Goila-Gaur, et al.. (2006). In Vitro Resistance to the Human Immunodeficiency Virus Type 1 Maturation Inhibitor PA-457 (Bevirimat). Journal of Virology. 80(22). 10957–10971. 98 indexed citations
11.
Wolf, Roman F., James F. Papin, Rebecca Hines‐Boykin, et al.. (2006). Baboon model for West Nile Virus infection and vaccine evaluation. Virology. 355(1). 44–51. 34 indexed citations
12.
Sakalian, Michael, et al.. (2005). Rescue of internal scaffold-deleted Mason-Pfizer monkey virus particle production by plasma membrane targeting. Virology. 345(2). 317–327. 6 indexed citations
13.
Sakalian, Michael, et al.. (2005). Localization of self-interacting domains within betaretrovirus Gag polyproteins. Virology. 332(2). 659–666. 9 indexed citations
14.
Xu, Lizhe, et al.. (2004). Cloning the human betaretrovirus proviral genome from patients with primary biliary cirrhosis†. Hepatology. 39(1). 151–156. 78 indexed citations
15.
Knejzlı́k, Zdeněk, Martin Strohalm, Lenka Sedláčková, et al.. (2004). Isolation and characterization of the Mason–Pfizer monkey virus p12 protein. Virology. 324(1). 204–212. 6 indexed citations
16.
Lanman, Jason, TuKiet T. Lam, Mark R. Emmett, et al.. (2004). Key interactions in HIV-1 maturation identified by hydrogen-deuterium exchange. Nature Structural & Molecular Biology. 11(7). 676–677. 149 indexed citations
17.
Hunter, Eric, et al.. (2002). Identification of a Minimal HIV-1 Gag Domain Sufficient for Self-Association. Virology. 294(1). 141–150. 25 indexed citations
18.
Lanman, Jason, TuKiet T. Lam, Stephen Barnes, et al.. (2002). Identification of Novel Interactions in HIV-1 Capsid Protein Assembly by High-resolution Mass Spectrometry. Journal of Molecular Biology. 325(4). 759–772. 174 indexed citations
19.
Sakalian, Michael & Eric Hunter. (1998). Molecular Events in the Assembly of Retrovirus Particles. Advances in experimental medicine and biology. 440. 329–339. 28 indexed citations
20.
Sakalian, Michael, Scott Parker, Robert Weldon, & Eric Hunter. (1996). Synthesis and assembly of retrovirus Gag precursors into immature capsids in vitro. Journal of Virology. 70(6). 3706–3715. 60 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026